المؤلفون: Maio, M., Amonkar, M. M., Norquist, J. M., Ascierto, P. A., Manzyuk, L., Motola-Kuba, D., Penel, Nicolas, Cassier, Philippe A., Bariani, G. M., de Jesus Acosta, A., Doi, T., Longo, F., Miller, W. H., Oh, D. Y., Gottfried, M., Wang, R., Norwood, K., Marabelle, Aurelien

المساهمون: Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Immunologie anti-tumorale et immunothérapie des cancers (ITIC), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre d'Investigation Clinique en Biotherapie des cancers (CIC 1428 , CBT 507 ), Institut Gustave Roussy (IGR)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.univ-lille.fr/hal-04573604Test ; European Journal of Cancer, 2022, European Journal of Cancer, 169, pp.188-197. ⟨10.1016/j.ejca.2022.03.040⟩.

مصطلحات موضوعية: Pembrolizumab, Health-related quality of life, Microsatellite instability, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35588692; hal-04573604; https://hal.univ-lille.fr/hal-04573604Test; https://hal.univ-lille.fr/hal-04573604/documentTest; https://hal.univ-lille.fr/hal-04573604/file/PIIS0959804922001885.pdfTest; PUBMED: 35588692

الإتاحة: https://doi.org/10.1016/j.ejca.2022.03.040Test
https://hal.univ-lille.fr/hal-04573604Test
https://hal.univ-lille.fr/hal-04573604/documentTest
https://hal.univ-lille.fr/hal-04573604/file/PIIS0959804922001885.pdfTest

المؤلفون: Latimer, N. R., Bell, H., Abrams, Keith R., Amonkar, M. M., Casey, M.

مصطلحات موضوعية: BRAF protein human, clinical trial, drug therapy, melanoma, trametinib

العلاقة: http://www.ncbi.nlm.nih.gov/pubmed/27172483Test; Cancer Medicine, 2016, 5 (5), pp. 806-815; http://hdl.handle.net/2381/38686Test

الإتاحة: https://doi.org/10.1002/cam4.643Test
http://hdl.handle.net/2381/38686Test

المؤلفون: Amonkar, M. M., Martin-Algarra, S., Demidov, L. V., Goodman, V., Grotzinger, K., Haney, P., Kämpgen, E., Karaszewska, B., Mauch, C., Miller Jr., W. H., Millward, M., Mirakhur, B., Rutkowski, P., Chiarion-Sileni, V., Swann, S., Hauschild, A., Grob, J.-J.

الوصول الحر: https://www.europeana.eu/item/2048441/item_UG4F54OU27WIESZFKA4OO3SZAD6V3NGT?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCaTest

المؤلفون: Schadendorf, D, Amonkar, M M, Milhem, M, Grotzinger, K, Demidov, L V, Rutkowski, P, Garbe, C, Dummer, R, Hassel, J C, Wolter, P, Mohr, P, Trefzer, U, Lefeuvre-Plesse, C, Rutten, A, Steven, N, Ullenhag, G, Sherman, L, Wu, F S, Patel, K, Casey, M, Robert, C

المصدر: Schadendorf, D; Amonkar, M M; Milhem, M; Grotzinger, K; Demidov, L V; Rutkowski, P; Garbe, C; Dummer, R; Hassel, J C; Wolter, P; Mohr, P; Trefzer, U; Lefeuvre-Plesse, C; Rutten, A; Steven, N; Ullenhag, G; Sherman, L; Wu, F S; Patel, K; Casey, M; Robert, C (2014). Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study. Annals of Oncology, 25(3):700-706.

مصطلحات موضوعية: Dermatology Clinic, 610 Medicine & health

وصف الملف: application/pdf

العلاقة: https://www.zora.uzh.ch/id/eprint/93240/1/572_Schadendorf_D_et_al._-_Ann_Oncol_2014.pdfTest; info:pmid/24504441; urn:issn:0923-7534

الإتاحة: https://doi.org/10.5167/uzh-9324010.1093/annonc/mdt580Test
https://www.zora.uzh.ch/id/eprint/93240Test/
https://www.zora.uzh.ch/id/eprint/93240/1/572_Schadendorf_D_et_al._-_Ann_Oncol_2014.pdfTest

المؤلفون: Grob, J.-J., Amonkar, M. M., Martin-Algarra, S., Demidov, L. V., Goodman, V., Grotzinger, K., Haney, P., Kämpgen, E., Karaszewska, B., Mauch, C., Miller Jr., W. H., Millward, M., Mirakhur, B., Rutkowski, P., Chiarion-Sileni, V., Swann, S., Hauschild, A.

مصطلحات موضوعية: ddc:610

وصف الملف: application/pdf

العلاقة: https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/7419Test; urn:nbn:de:bvb:29-opus4-74190; https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-74190Test; https://doi.org/10.1093/annonc/mdu154Test; https://opus4.kobv.de/opus4-fau/files/7419/Grob_patient.pdfTest

الإتاحة: https://doi.org/10.1093/annonc/mdu154Test
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/7419Test
https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-74190Test
https://opus4.kobv.de/opus4-fau/files/7419/Grob_patient.pdfTest

المؤلفون: Schadendorf, D., Amonkar, M. M., Milhem, M., Grotzinger, K., Demidov, L. V., Rutkowski, P., Garbe, C., Dummer, R., Hassel, J. C., Wolter, P., Mohr, P., Trefzer, U., Lefeuvre-Plesse, C., Rutten, A., Steven, N., Ullenhag, G., Sherman, L., Wu, F. S., Patel, K., Casey, M., Robert, C.

مصطلحات موضوعية: Original article

وصف الملف: text/html

العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/mdt580v1Test; http://dx.doi.org/10.1093/annonc/mdt580Test

الإتاحة: https://doi.org/10.1093/annonc/mdt580Test
http://annonc.oxfordjournals.org/cgi/content/short/mdt580v1Test

المؤلفون: Wu, Y., Amonkar, M. M., Sherrill, B. H., O’Shaughnessy, J., Ellis, C., Baselga, J., Blackwell, K. L., Burstein, H. J.

مصطلحات موضوعية: original article

وصف الملف: text/html

العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/mdr014v1Test; http://dx.doi.org/10.1093/annonc/mdr014Test

الإتاحة: https://doi.org/10.1093/annonc/mdr014Test
http://annonc.oxfordjournals.org/cgi/content/short/mdr014v1Test

المؤلفون: Riemsma, Rob, Forbes, C. A., Kessels, A., Lykopoulos, K., Amonkar, M. M., Rea, D. W., Kleijnen, J.

المساهمون: Kleijnen Systematic Reviews Ltd., Maastricht University Maastricht, GlaxoSmithKline, Institute for Cancer Studies, University of Birmingham Birmingham

المصدر: ISSN: 0167-6806.

مصطلحات موضوعية: Systematic review, Aromatase inhibitors, First-line treatment, Hormone sensitive advanced or metastatic breast cancer

العلاقة: hal-00545276; https://hal.science/hal-00545276Test; https://hal.science/hal-00545276/documentTest; https://hal.science/hal-00545276/file/PEER_stage2_10.1007%252Fs10549-010-0974-0.pdfTest

الإتاحة: https://doi.org/10.1007/s10549-010-0974-0Test
https://hal.science/hal-00545276Test
https://hal.science/hal-00545276/documentTest
https://hal.science/hal-00545276/file/PEER_stage2_10.1007%252Fs10549-010-0974-0.pdfTest

المؤلفون: Sherrill, B, Amonkar, M M, Stein, S, Walker, M, Geyer, C, Cameron, D

المصدر: British Journal of Cancer ; volume 99, issue 5, page 711-715 ; ISSN 0007-0920 1532-1827

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1038/sj.bjc.6604501Test
http://www.nature.com/articles/6604501.pdfTest
http://www.nature.com/articles/6604501Test

المؤلفون: Grob, J. -J., Amonkar, M. M., Martin-Algarra, S., Demidov, L. V., Goodman, V., Grotzinger, K., Haney, P., Kaempgen, E., Karaszewska, B., Mauch, C., Miller, W. H., Jr., Millward, M., Mirakhur, B., Rutkowski, P., Chiarion-Sileni, V., Swann, S., Hauschild, A.

مصطلحات موضوعية: ddc:no

العلاقة: Grob, J. -J., Amonkar, M. M., Martin-Algarra, S., Demidov, L. V., Goodman, V., Grotzinger, K., Haney, P., Kaempgen, E., Karaszewska, B., Mauch, C., Miller, W. H., Jr., Millward, M., Mirakhur, B., Rutkowski, P., Chiarion-Sileni, V., Swann, S. and Hauschild, A. (2014). Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine. Ann. Oncol., 25 (7). S. 1428 - 1437. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

الإتاحة: https://kups.ub.uni-koeln.de/43512Test/